Human epidermal growth factor receptor 2 (HER-2), as a crucial factorinvolved in about 20% of breast cancer cases, is one of the most reliable tumor markersto determine prognosis and therapeutic trend of this disease. Here, ERBB2 is linked to breast cancer.